These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5954555)

  • 21. [Long-cycle oral contraceptives--a progress?].
    Kvan E; Narum S
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2202-3. PubMed ID: 16138136
    [No Abstract]   [Full Text] [Related]  

  • 22. Menstrual manipulation: options for suppressing the cycle.
    Hicks CW; Rome ES
    Cleve Clin J Med; 2010 Jul; 77(7):445-53. PubMed ID: 20601618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The menstrual cycle after oral contraceptives].
    Hauser GA; Girotti M
    Geburtshilfe Frauenheilkd; 1967 Jun; 27(6):626-30. PubMed ID: 5592760
    [No Abstract]   [Full Text] [Related]  

  • 24. [Indications and treatment of menstrual disorders with a synthetic progestational hormone, ethynodiol diacetate alone or combined in variable doses with an estrogen].
    Soutoul JH
    Rev Fr Gynecol Obstet; 1969; 64(1):41-55. PubMed ID: 5362109
    [No Abstract]   [Full Text] [Related]  

  • 25. [Our experience with a sequential estro-progestinic agent. Its use in disorders of the menstrual cycle and in the dysautonomic syndrome of the premenopausal period].
    Accinelli G; Cortellardo G; Santoni G; Sbernini R
    Minerva Ginecol; 1976 Feb; 28(2):175-81. PubMed ID: 1256718
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of lynestrenol (Orgametril) in the treatment of menstrual cycle disorders].
    Kloś J; Potocki J
    Ginekol Pol; 1968 Jan; 39(1):49-58. PubMed ID: 5665493
    [No Abstract]   [Full Text] [Related]  

  • 27. [Action of dydrogesterone in postpubertal menstruation disorders].
    Tabaste JL; Servaud M; Steiner E; Dabir P; Bene B; Pouzet M
    Rev Fr Gynecol Obstet; 1984 Jan; 79(1):19-20, 23-5. PubMed ID: 6531584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ambulatory treatment of menstrual disorders after menarche].
    Finková A
    Cesk Gynekol; 1975 Mar; 40(2):89-90. PubMed ID: 1169125
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lutenyl and menstrual disorders. A hospital study].
    Cohen A; Engelmann P; Erny R; Favier M; Ghéron G
    Rev Fr Gynecol Obstet; 1988 Nov; 83(11):741-3. PubMed ID: 3206099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pre-menstrual tension].
    Mizuno M
    Horumon To Rinsho; 1974 Jan; 22(1):110-1. PubMed ID: 4857369
    [No Abstract]   [Full Text] [Related]  

  • 31. Targeted treatment strategies for menstrual migraine.
    Martin V
    J Fam Pract; 2007 Feb; 56(2 Suppl Pain):13-22. PubMed ID: 17270114
    [No Abstract]   [Full Text] [Related]  

  • 32. [Modern therapy with micronized of progesterone--utrogestan for menstrual disturbances].
    Sirakov M
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():22-4. PubMed ID: 11785350
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of noracycline administered in menstrual disturbances on certain biological functions in the female organism].
    Jabloński K; Giermańska T; Filc-Bauer A
    Pol Tyg Lek; 1970 Sep; 25(36):1361-3. PubMed ID: 5470622
    [No Abstract]   [Full Text] [Related]  

  • 34. [Behavior of total 17-ketosteroids and corticosteroids in urine in menstrual cycle disorders and in Stein-Leventhal syndrome treated with clomiphene].
    Ingrassia F; Morresi G; Barciulli F
    Riv Ostet Ginecol; 1968 Aug; 23(8):623-30. PubMed ID: 5703923
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of menstruation in severe learning disability.
    McMahon M; Huyton M; Hindley D
    Arch Dis Child; 2008 Feb; 93(2):181-2. PubMed ID: 18208997
    [No Abstract]   [Full Text] [Related]  

  • 36. Mayo Clinic office visit. Menstrual manipulation.
    Abboud R
    Mayo Clin Womens Healthsource; 2003 Dec; 7(12):suppl 1-2. PubMed ID: 14639254
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduction of menstrual blood loss by prostaglandin synthetase inhibitor.
    Anuman-Rajadhon Y; Amatyakul A; Tungsubutra V
    J Med Assoc Thai; 1982 Nov; 65(11):575-9. PubMed ID: 7161583
    [No Abstract]   [Full Text] [Related]  

  • 38. [Oxyprogesterone capronate in the treatment of menstrual epilepsy].
    Badalian LO; Temin PA; Mukhin KIu
    Ross Med Zh; 1992; (3):41-4. PubMed ID: 1643360
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulation of disorders of the menstrual cycle with special reference to sterility.
    Lunenfeld B
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):512-6. PubMed ID: 5510176
    [No Abstract]   [Full Text] [Related]  

  • 40. [Description of a new method of ovarian inhibition: the "sequential method". Results of its use in the treatment of dysmenorrheas and inter-menstrual disorders. (Study of 172 subjects treated during 573 cycles)].
    Gueguen J
    Rev Fr Gynecol Obstet; 1967 Jun; 62(6):279-86. PubMed ID: 4193181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.